Multimodality Imaging Assessment of Myocardial Fibrosis

JACC-CARDIOVASCULAR IMAGING

卷:14

Review

Gupta, Sumit^1,2  Ge, Yin^1,2,3  Singh, Amitoj^1,2  Grani, Christoph^1,2  Kwong, Raymond Y.^1,2 

[1] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Noninvas Cardiovasc Imaging Sect, Div Cardiovasc, Dept Med, Boston, MA 02115 USA

[3] Univ Toronto, Div Cardiol, Dept Med, St Michaels Hosp, Toronto, ON, Canada

关键词: cardiac computed tomography;    cardiac magnetic resonance;    late gadolinium enhancement;    myocardial fibrosis;    nuclear imaging;    T1 mapping;   

DOI  :  10.1016/j.jcmg.2021.01.027

来源: Elsevier

【 摘 要 】

Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and quantification of myocardial fibrosis with the use of an expanding array of techniques including cardiac magnetic resonance, computed tomography, and nuclear imaging. This review discusses currently available noninvasive imaging techniques, provides insights into their strengths and limita-tions, and examines novel developments that will affect the future of noninvasive imaging of myocardial fibrosis. (J Am Coll Cardiol Img 2021;14:2457-2469) (c) 2021 by the American College of Cardiology Foundation.

【 授权许可】

Free